GET THE APP

Chemotherapy: Open Access

Chemotherapy: Open Access
Open Access

ISSN: 2167-7700

+44 1223 790975

Chemotherapy: Open Access : Citations & Metrics Report

Articles published in Chemotherapy: Open Access have been cited by esteemed scholars and scientists all around the world. Chemotherapy: Open Access has got h-index 12, which means every article in Chemotherapy: Open Access has got 12 average citations.

Following are the list of articles that have cited the articles published in Chemotherapy: Open Access.

  2021 2020 2019 2018 2017 2016

Year wise published articles

30 8 0 17 24 52

Year wise citations received

61 68 83 58 143 116
Journal total citations count 709
Journal impact factor 1.81
Journal 5 years impact factor 3.80
Journal cite score 4.89
Journal h-index 12
Journal h-index since 2018 9
Important citations (402)

raja ramesh gv. cancer metastasis and its suppressor genes. biochem mol biol lett. 2017;3(2):116.

satya srinivas v. research and reviews: journal of medical and health sciences.

anitha sri s, prudhvi raj p. incidence and prevalence of breast cancer in usa. biochem mol biol lett. 2017;2(1):102.

joyal v. research and reviews: journal of pharmacy and pharmaceutical sciences neoplastic diseases: a mini-review.

tripathi s, madan a. biomarkers role in breast cancer treatment-a review.

raja ramesh gv. cancer metastasis and its suppressor genes. biochem mol biol lett. 2017;3(2):116.

joyal v. research and reviews: journal of pharmacy and pharmaceutical sciences neoplastic diseases: a mini-review.

tripathi s, madan a. biomarkers role in breast cancer treatment-a review.

azad ma. journal of medical and health sciences.

raja ramesh gv. cancer metastasis and its suppressor genes. biochem mol biol lett. 2017;3(2):116.

rachana n. research & reviews: journal of pharmaceutics and nanotechnology.

vitiello m, palma g, monaco m, bello am, camorani s, francesca p, rea d, barbieri a, chiappetta g, vita gd, cerchia l. dual oncogenic/anti-oncogenic role of patz1 in frtl5 rat thyroid cells transformed by the ha-rasv12 oncogene. genes. 2019;10(2):127.

mounika m. research & reviews: journal of pharmacology and toxicological studies.

joyal v. research and reviews: journal of pharmacy and pharmaceutical sciences neoplastic diseases: a mini-review.

tripathi s, madan a. biomarkers role in breast cancer treatment-a review.

monaco m, palma g, vitiello m, capiluongo a, d’andrea b, vuttariello e, luciano a, cerchia l, chiappetta g, arra c, fusco a. loss of one or two patz1 alleles has a critical role in the progression of thyroid carcinomas induced by the ret/ptc1 oncogene. cancers. 2018;10(4):92.

fedele m, crescenzi e, cerchia l. the poz/btb and at-hook containing zinc finger 1 (patz1) transcription regulator: physiological functions and disease involvement. international journal of molecular sciences. 2017;18(12):2524.

tomita k, takashi y, ouchi y, kuwahara y, igarashi k, nagasawa t, et al. lipid peroxidation increases hydrogen peroxide permeability leading to cell death in cancer cell lines that lack mtdna. cancer science. 2019;110(9):2856.

thakur c. research & reviews: journal of medical and health sciences.

chakraborty s, dile zy, chakraborty s, roy s, mukherjee b, besra se, chakraborty a, sen r, dewanjee s, mukherjee a, ojha pk. tls 9a functionalized nanocarrier predominantly delivers drug to neoplastic hepatocytes.

Relevant Topics

Top